A new study out of Denmark shows that clinically silent coronary plaques was linked to a substantially elevated heart attack risk in middle-aged persons without known cardiovascular disease.
#coronaryarterydisease#plaques#hearta…https://t.co/qfNfKz3os3 https://t.co/3BE8Jxj8aF
Momentum is growing for CCTA as a cardiac screening test.
“Researchers found that CCTA was remarkably effective in identifying individuals without symptoms who were more likely to experience heart attacks in years to come.”
#Yes…https://t.co/oDpf5O28WH https://t.co/9FcdxWeVBJ
Photon counting CT is the future of coronary artery disease and atherosclerotic plaque assessment. Amazing imagery showing the clarity of this new imaging technology. #photoncounting#CT#atherosclerosis#plaque Siemens Healthineers GE Healthcare https://t.co/3yZ1H1sJrs
This is a significant milestone for Artrya, enabling us to market into the United Kingdom and supply Salix Coronary Anatomy to 1250 NHS Trust Hospitals. This makes Salix one of very few companies providing plaque analysis within the UK. #nhs#hospitals#p…https://t.co/VcOtn1vFrN
Artrya announced today it has received regulatory approval for its Salix Coronary Anatomy (SCA) product in Europe.
Managing Director and CEO John Barrington AM said this was an important moment for the company.
View full announcement: https://t.co/MJrdF0hT8g
Huge achievement today for Artrya Ltd in receiving CE Mark regulatory approval. This enables a significant opportunity to provide Artrya's non-invasive solution Salix Coronary Anatomy in Europe and provide clinicians with a more comprehensive understandin…https://t.co/HOUERHex3p
Great news with newly assigned reimbursement code and payment rate by CMS for the assessment, quantification, and characterisation of atherosclerotic plaque from CCTA. This is a major milestone and further support for CCTA as a fir…https://t.co/jflnf7uo3j https://t.co/iMQHLaB81J
The latest CAD-RADS coronary CT guidelines are out.
“Even though coronary CTA can be a very useful test when performed on the right patient population, the test itself does not change outcomes. Rather, it is how clinicians act on…https://t.co/dJIprBJp8u https://t.co/C7VUVpgWnH
Excited to share our clinical partnership with The Heart Center, Huntsville AL. This is a major step for Artrya Ltd in validating AI for heart disease diagnosis. #ai#coronaryarterydisease#clinicalresearch Michael Ridner https://t.co/MSsJVplPbH